Stock Update (NYSE:PFE): FDA panel votes to keep severe warning on Pfizer anti-smoking drug

[Reuters] – Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting . . . → Read More: Stock Update (NYSE:PFE): FDA panel votes to keep severe warning on Pfizer anti-smoking drug Similar Articles: Market Update: Pfizer Inc (NYSE:PFE) – FDA staff wants Pfizer to keep black box warning on anti-smoking drug Pfizer Inc (NYSE:PFE) – French biotech Cellectis surges as Pfizer signs cancer drug deal Company Update (NYSE:PFE): Second UK lawmaker panel to call Pfizer, AstraZeneca over bid